4//SEC Filing
Schuth Alexander O. 4
Accession 0001714899-24-000218
CIK 0001714899other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:44 PM ET
Size
13.5 KB
Accession
0001714899-24-000218
Insider Transaction Report
Form 4
Schuth Alexander O.
COFO and Secretary
Transactions
- Sale
Common Stock
2024-11-07$29.68/sh−12,333$366,043→ 181,291 total - Sale
Common Stock
2024-11-07$31.29/sh−300$9,387→ 178,066 total - Sale
Common Stock
2024-11-07$30.72/sh−2,925$89,856→ 178,366 total - Exercise/Conversion
Common Stock
2024-11-07$5.28/sh+15,558$82,146→ 193,624 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-07−15,558→ 53,379 totalExercise: $5.28Exp: 2027-03-07→ Common Stock (15,558 underlying)
Holdings
- 523,749(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]Includes 118,810 Unvested RSUs.
- [F2]The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.
- [F3]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.21 to $30.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.21 to $31.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F5]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.27 to $31.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F6]The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
- [F7]25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001724311
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:44 PM ET
- Size
- 13.5 KB